Jun 9 2015
The Hematology/Oncology Pharmacy Association (HOPA) will present the HOPA Oncology Pharmacy Practice Management Program at the Hilton Rosemont/Chicago O'Hare on September 18-19, 2015, in Rosemont, IL. The program will examine how to provide a high level of clinical practice when patients demand more, but front offices and third-party payers require it be done with less. This balancing act has become increasingly difficult as oncology practices are challenged with providing newer, more expensive treatments.
The HOPA Oncology Pharmacy Practice Management Program will offer perspectives from leaders who have achieved success in providing top-of-the line clinical care in a fiscally responsible manner. Program leaders will offer practical solutions for challenges you may face at your facility.
This robust program will delve into several areas of pharmacy services. Program highlights include:
• USP <800> Compliance
• Standardized Training Programs
• Billing and Reimbursement
• Medication Assistance Programs
• Networking with the Experts
This program is intended for oncology pharmacists, pharmacy managers, pharmacy directors, oncology residents, administrative residents, oncology business managers, and oncology informatics pharmacists.
Upon completion of the program, participants will be able to
• Describe ways to motivate pharmacists to maximize opportunities to provide patient care
• Discuss oncology pharmacy best practices and guidelines
• Develop ways to improve patient outcomes through specialty pharmacy programs
• Review approaches that prove the value of oncology pharmacy practice
• Outline processes to maximize reimbursement from third-party payers
Attendees will have the opportunity to attend a preconference workshop, Utilizing Medication Assistance Programs, Handling Off-Label Requests, Managing High Dollar Medications, and Other Financial Pearls for a Bright Financial Outlook. Available for an additional fee, this event will include a variety of topics geared toward assisting organizations in maximizing revenue, minimizing write-offs, and assisting patients who have difficulty affording their medications.
Source: HOPA